Upgrade to SI Premium - Free Trial

Spero Therapeutics (SPRO) PT Raised to $6 at H.C. Wainwright

September 14, 2026 6:56 AM
H.C. Wainwright analyst Raghuam Selvaraju raised the price target on Spero Therapeutics (NASDAQ: SPRO) to $6.00 (from $5.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change